Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

JAMA Neurology Author Interviews - En podkast av JAMA Network - Mandager

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

Visit the podcast's native language site